AstraZeneca acquired MedImmune in 2007. MedImmune was a biotechnology company focused on developing innovative medicines in areas such as oncology, respiratory, and cardiovascular diseases. This acquisition expanded AstraZeneca's biologics capabilities and pipeline.
Unlock the AstraZeneca Enigma: The Ultimate Quiz on the British Pharma Giant!